Literature DB >> 33478586

The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.

Xueying Wang1, Junnan Guo2, Pingyang Yu1, Lunhua Guo1, Xionghui Mao1, Junrong Wang1, Susheng Miao3, Ji Sun4.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the main malignant tumours affecting human health, mainly due to delayed diagnosis and high invasiveness. Extracellular vehicles (EVs) are membranous vesicles released by cells into the extracellular matrix that carry important signalling molecules and stably and widely exist in various body fluids, such as plasma, saliva, cerebrospinal fluid, breast milk, urine, semen, lymphatic fluid, synovial fluid, amniotic fluid, and sputum. EVs transport almost all types of bioactive molecules (DNA, mRNAs, microRNAs (miRNAs), proteins, metabolites, and even pharmacological compounds). These "cargoes" can act on recipient cells, reshaping the surrounding microenvironment and altering distant targets, ultimately affecting their biological behaviour. The extensive exploration of EVs has deepened our comprehensive understanding of HNSCC biology. In this review, we not only summarized the effect of HNSCC-derived EVs on the tumour microenvironment but also described the role of microenvironment-derived EVs in HNSCC and discussed how the "mutual dialogue" between the tumour and microenvironment mediates the growth, metastasis, angiogenesis, immune escape, and drug resistance of tumours. Finally, the clinical application of EVS in HNSCC was assessed.

Entities:  

Keywords:  Drug resistance; EXOs; Extracellular vesicles; Head and neck squamous cell carcinoma; Tumour microenvironment

Year:  2021        PMID: 33478586      PMCID: PMC7819156          DOI: 10.1186/s13046-021-01840-x

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  198 in total

1.  IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.

Authors:  Yujia Zheng; Yu Li; Bo Tang; Qitai Zhao; Dan Wang; Yulin Liu; Mengxing Guo; Song Zhao; Yu Qi; Yi Zhang; Lan Huang
Journal:  Cancer Immunol Immunother       Date:  2020-06-10       Impact factor: 6.968

2.  Macrophage heterogeneity and tissue lipids.

Authors:  Siamon Gordon
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Membrane bending by protein-protein crowding.

Authors:  Jeanne C Stachowiak; Eva M Schmid; Christopher J Ryan; Hyoung Sook Ann; Darryl Y Sasaki; Michael B Sherman; Phillip L Geissler; Daniel A Fletcher; Carl C Hayden
Journal:  Nat Cell Biol       Date:  2012-08-19       Impact factor: 28.824

Review 4.  Extracellular vesicles: biology and emerging therapeutic opportunities.

Authors:  Samir EL Andaloussi; Imre Mäger; Xandra O Breakefield; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2013-04-15       Impact factor: 84.694

5.  Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins.

Authors:  Yuk-Kit Chan; Huoming Zhang; Pei Liu; Sai-Wah Tsao; Maria Li Lung; Nai-Ki Mak; Ricky Ngok-Shun Wong; Patrick Ying-Kit Yue
Journal:  Int J Cancer       Date:  2015-04-29       Impact factor: 7.396

6.  HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.

Authors:  Fangjia Tong; Xionghui Mao; Siwei Zhang; Huanhuan Xie; Bingqing Yan; Bozhi Wang; Ji Sun; Lanlan Wei
Journal:  Cancer Lett       Date:  2020-02-29       Impact factor: 8.679

7.  Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.

Authors:  Tomoyoshi Sanada; Afsana Islam; Teppei Kaminota; Yui Kirino; Reina Tanimoto; Hana Yoshimitsu; Hajime Yano; Yosuke Mizuno; Masahiro Okada; Souhei Mitani; Tohru Ugumori; Junya Tanaka; Naohito Hato
Journal:  Laryngoscope       Date:  2019-06-20       Impact factor: 3.325

8.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

Authors:  Anders Näsman; Per Attner; Lalle Hammarstedt; Juan Du; Mathilda Eriksson; Geraldine Giraud; Sofie Ahrlund-Richter; Linda Marklund; Mircea Romanitan; David Lindquist; Torbjörn Ramqvist; Johan Lindholm; Pär Sparén; Weimin Ye; Hanna Dahlstrand; Eva Munck-Wikland; Tina Dalianis
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

10.  Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.

Authors:  Shinya Sento; Eri Sasabe; Tetsuya Yamamoto
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more
  13 in total

1.  In vitro experimental study on the formation of microRNA-34a loaded exosomes and their inhibitory effect in oral squamous cell carcinoma.

Authors:  Wei Deng; Ying Meng; Bin Wang; Chen-Xing Wang; Chen-Xing Hou; Qing-Hai Zhu; Yu-Ting Tang; Jin-Hai Ye
Journal:  Cell Cycle       Date:  2022-04-29       Impact factor: 5.173

2.  Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells.

Authors:  Junjie Gou; Hongjiao Li; Jingjing Bi; Xingchen Pang; Xiang Li; Yi Wang
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

Review 3.  Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.

Authors:  Yu-Shui Ma; Ji-Bin Liu; Xiao-Li Yang; Rui Xin; Yi Shi; Dan-Dan Zhang; Hui-Min Wang; Pei-Yao Wang; Qin-Lu Lin; Wen Li; Da Fu
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 4.  Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.

Authors:  Vasudha Mishra; Alka Singh; Xiangying Chen; Ari J Rosenberg; Alexander T Pearson; Alex Zhavoronkov; Peter A Savage; Mark W Lingen; Nishant Agrawal; Evgeny Izumchenko
Journal:  Br J Cancer       Date:  2021-12-07       Impact factor: 7.640

Review 5.  Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.

Authors:  Kaibo Guo; Yuqian Feng; Xueer Zheng; Leitao Sun; Harpreet S Wasan; Shanming Ruan; Minhe Shen
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

6.  Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.

Authors:  Tongwu Bie; Xuewen Zhang
Journal:  J Immunol Res       Date:  2021-12-23       Impact factor: 4.818

7.  Hsp70-containing extracellular vesicles are capable of activating of adaptive immunity in models of mouse melanoma and colon carcinoma.

Authors:  Elena Y Komarova; Roman V Suezov; Alina D Nikotina; Nikolay D Aksenov; Luiza A Garaeva; Tatiana A Shtam; Alexander V Zhakhov; Marina G Martynova; Olga A Bystrova; Maria S Istomina; Alexander M Ischenko; Boris A Margulis; Irina V Guzhova
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

Review 8.  Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment.

Authors:  Yuanxin Xu; Kuanhan Feng; Huacong Zhao; Liuqing Di; Lei Wang; Ruoning Wang
Journal:  Theranostics       Date:  2022-01-16       Impact factor: 11.556

9.  The Chaperone Protein GRP78 Promotes Survival and Migration of Head and Neck Cancer After Direct Radiation Exposure and Extracellular Vesicle-Transfer.

Authors:  Michael Schneider; Klaudia Winkler; Rosemarie Kell; Michael W Pfaffl; Michael J Atkinson; Simone Moertl
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

10.  Effect of interleukin-8 receptor B (IL8RB) rs1126579 C>T variation on the risk to cancer.

Authors:  Lihong Zhu; Bowen Tang; Ze Zhang; Shuzhang Wei; Zhiwei Lv; Yujuan Zhang; Minlie Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.